NCT05973812View on ClinicalTrials.gov

Safety of Bifidobacterium Breve PS1 for Infants

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 12, 2012

Primary Completion Date

July 29, 2014

Study Completion Date

March 12, 2015

Conditions
Infant DevelopmentSafety Issues
Interventions
DIETARY_SUPPLEMENT

Infant formula supplemented with Bifidobacterium breve PS1

Feeding with an infant formula containing 7 log10 cfu of the strain per gram of formula.

DIETARY_SUPPLEMENT

Infant formula NOT supplemented with Bifidobacterium breve PS1

Feeding with the same infant formula but without supplementation with the B. breve strain

Trial Locations (3)

28007

Hospital Gregorio Marañón, Madrid

28040

Universidad Complutense de Madrid, Madrid

28043

Centro de Atención Primaria Silvano, Madrid

All Listed Sponsors
lead

Universidad Complutense de Madrid

OTHER

collaborator

Hospital General Universitario Gregorio Marañon

OTHER

collaborator

Gerencia de Atención Primaria, Madrid

OTHER_GOV

NCT05973812 - Safety of Bifidobacterium Breve PS1 for Infants | Biotech Hunter | Biotech Hunter